Literature DB >> 19768690

Modelling the association between patient characteristics and the change over time in a disease measure using observational cohort data.

L Harrison1, D T Dunn, H Green, A J Copas.   

Abstract

In observational cohort studies we may wish to examine the associations between fixed patient characteristics and the longitudinal changes from baseline in a repeated outcome measure. Many biological and other outcome measures are known to be subject to measurement error and biological variation. In an initial analysis we may fit a regression model to all outcome measurements, accounting for all the identified sources of variability, and see how the characteristics are linked to the change for typical patients. However, the characteristics may also be linked to different distributions of the underlying outcome value at baseline, which itself may be correlated with the change over time. Therefore, if we wish to examine the change over time for patients of different characteristics but with the same underlying baseline value then the initial approach is confounded by the baseline values. Furthermore, if we attempt to remove this confounding by including the observed baseline measure as a covariate in a model for later measurements, then this may provide an approximate solution but is likely to introduce some bias. We propose a method based on first following the initial approach but then, applying a correction to the parameter estimates. This allows the predicted trajectories to be plotted and valid significance tests of association with characteristics. Our approach is compared with other methods and illustrated through a simulation study and an analysis of the association between HIV-1 subtype and immunological response after starting antiretroviral therapy.

Entities:  

Mesh:

Year:  2009        PMID: 19768690     DOI: 10.1002/sim.3725

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  9 in total

1.  Should Studies of Diabetes Treatment Stratification Correct for Baseline HbA1c?

Authors:  Angus G Jones; Mike Lonergan; William E Henley; Ewan R Pearson; Andrew T Hattersley; Beverley M Shields
Journal:  PLoS One       Date:  2016-04-06       Impact factor: 3.240

2.  Combined models for pre- and post-treatment longitudinal biomarker data: an application to CD4 counts in HIV-patients.

Authors:  Oliver T Stirrup; Abdel G Babiker; Andrew J Copas
Journal:  BMC Med Res Methodol       Date:  2016-09-15       Impact factor: 4.615

3.  Immunologic response in treatment-naïve HIV-2-infected patients: the IeDEA West Africa cohort.

Authors:  Eric Balestre; Didier Koumavi Ekouevi; Boris Tchounga; Serge Paul Eholie; Eugène Messou; Adrien Sawadogo; Rodolphe Thiébaut; Margaret T May; Jonathan Ac Sterne; François Dabis
Journal:  J Int AIDS Soc       Date:  2016-02-08       Impact factor: 5.396

4.  Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family Study.

Authors:  Rozenn N Lemaitre; Chaoyu Yu; Andrew Hoofnagle; Nair Hari; Paul N Jensen; Amanda M Fretts; Jason G Umans; Barbara V Howard; Colleen M Sitlani; David S Siscovick; Irena B King; Nona Sotoodehnia; Barbara McKnight
Journal:  Diabetes       Date:  2018-03-27       Impact factor: 9.461

5.  Precision MRI phenotyping enables detection of small changes in body composition for longitudinal cohorts.

Authors:  Brandon Whitcher; Marjola Thanaj; Madeleine Cule; Yi Liu; Nicolas Basty; Elena P Sorokin; Jimmy D Bell; E Louise Thomas
Journal:  Sci Rep       Date:  2022-03-08       Impact factor: 4.379

6.  Changes in Body Mass Index after Initiation of Antiretroviral Treatment: Differences by Class of Core Drug.

Authors:  Nikos Pantazis; Vasilios Papastamopoulos; Anastasia Antoniadou; Georgios Adamis; Vasilios Paparizos; Simeon Metallidis; Helen Sambatakou; Mina Psichogiou; Maria Chini; Georgios Chrysos; Periklis Panagopoulos; Nikolaos V Sipsas; Emmanouil Barbunakis; Charalambos Gogos; Giota Touloumi
Journal:  Viruses       Date:  2022-07-29       Impact factor: 5.818

7.  The impact of transient combination antiretroviral treatment in early HIV infection on viral suppression and immunologic response in later treatment.

Authors:  Nikos Pantazis; Giota Touloumi; Laurence Meyer; Ashley Olson; Dominique Costagliola; Anthony D Kelleher; Irja Lutsar; Marie-Laure Chaix; Martin Fisher; Santiago Moreno; Kholoud Porter
Journal:  AIDS       Date:  2016-03-27       Impact factor: 4.177

Review 8.  Test-retest reliability of longitudinal task-based fMRI: Implications for developmental studies.

Authors:  Megan M Herting; Prapti Gautam; Zhanghua Chen; Adam Mezher; Nora C Vetter
Journal:  Dev Cogn Neurosci       Date:  2017-07-13       Impact factor: 6.464

9.  Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved?

Authors:  Inma Jarrin; Nikos Pantazis; Judith Dalmau; Andrew N Phillips; Ashley Olson; Cristina Mussini; Faroudy Boufassa; Dominique Costagliola; Kholoud Porter; Juliá Blanco; Julia Del Amo; Javier Martinez-Picado
Journal:  AIDS       Date:  2015-11       Impact factor: 4.177

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.